Business Description
Nu-Med Plus Inc
NAICS : 339112
SIC : 3841
ISIN : US67021R1041
Description
Nu-Med Plus Inc is an medical device company principally engaged in the design, innovation, development, enhancement, and commercialization of beginning, early, and selective later-stage quality medical devices. It focuses on the formulation of Nitric Oxide powder, which is a desktop generator device which delivers inhaled Nitric Oxide to replace expensive pressurized canisters and a mobile rechargeable device to deliver inhaled Nitric Oxide gas to offer solutions to hospitals, health systems and medical community throughout the world.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.04 | |||||
| Equity-to-Asset | -29.29 | |||||
| Debt-to-Equity | -0.49 | |||||
| Debt-to-EBITDA | -0.92 | |||||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 69.7 | |||||
| 3-Year EPS without NRI Growth Rate | 63.2 | |||||
| 3-Year FCF Growth Rate | 50 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 24.21 | |||||
| 9-Day RSI | 31.15 | |||||
| 14-Day RSI | 33.94 | |||||
| 6-1 Month Momentum % | -76.42 | |||||
| 12-1 Month Momentum % | -49.66 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.03 | |||||
| Quick Ratio | 0.03 | |||||
| Cash Ratio | 0.02 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -17.9 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -1064.81 | |||||
| ROIC % | -109 | |||||
| 3-Year ROIIC % | -956.12 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -8.17 | |||||
| EV-to-EBITDA | -8.17 | |||||
| EV-to-FCF | -55.12 | |||||
| Earnings Yield (Greenblatt) % | -12.24 | |||||
| FCF Yield % | -3.15 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:NUMD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nu-Med Plus Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.001 | ||
| Beta | 1.96 | ||
| Volatility % | 130.39 | ||
| 14-Day RSI | 33.94 | ||
| 14-Day ATR ($) | 0.001685 | ||
| 20-Day SMA ($) | 0.013653 | ||
| 12-1 Month Momentum % | -49.66 | ||
| 52-Week Range ($) | 0.0095 - 0.09 | ||
| Shares Outstanding (Mil) | 83.55 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nu-Med Plus Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nu-Med Plus Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Nu-Med Plus Inc Frequently Asked Questions
What is Nu-Med Plus Inc(NUMD)'s stock price today?
The current price of NUMD is $0.01. The 52 week high of NUMD is $0.09 and 52 week low is $0.01.
When is next earnings date of Nu-Med Plus Inc(NUMD)?
The next earnings date of Nu-Med Plus Inc(NUMD) is .
Does Nu-Med Plus Inc(NUMD) pay dividends? If so, how much?
Nu-Med Plus Inc(NUMD) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers